2015 - Healthcare for Women Over 40

THU730 - Benefits and Limitations of GYN and Cancer Screening for Women Over 40

Content Origination Date: Apr 23, 2015 ‐ Content Expiration Date: May 15, 2018

Standard: $15.00


Learning Objectives:

  • List criteria for identifying women at increased risk for each of the GYN cancers. 
  • Describe screening recommendations for each cancer for general population and for women at increased risk. 
  • Outline approaches to reduce risks for each GYN cancer. 



  • Bayer, Agile, Grants/Research; Actavis, Bayer Merck, Honoraria/Speakers Bureau; Pfizer, Teva, Honoraria/Speakers Bureau; Actavis, Agile, Bayer, ContraMed, Consultant/Advisory Board;  Merck, Teva, MicroCHIPS, PharmaNest, Consultant/Advisory Board


  • 1.50 - Physician
  • 1.50 - RN / NP (All RNs/Nurses except CA RNs)
  • 1.50 - CA RN/CA BRN

You must be logged in and own this session in order to post comments.